LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study

作者：Akihito Kawazoe, Rui‐Hua Xu, Maria Passhak, Hao‐Wei Teng, Ardaman Shergill, M. Gumus, Camilla Qvortrup, Sebastian Stintzing, Kathryn Towns, T. Kim, Kai‐Keen Shiu, Juan Cundom, S. Ananda, A. A. Lebedinets, Roxana Fu, Rajeev Jain, David E. Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Élez · 发表于：Annals of Oncology · 年份：2023 · DOI：10.1016/j.annonc.2023.04.015 · 被引用次数：27 · 研究领域：Genetic factors in colorectal cancer、Colorectal Cancer Treatments and Studies、Cancer Immunotherapy and Biomarkers